Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes

Erythropoiesis-Stimulating Agents — Time for a Reevaluation

(2010) Ellis F. Unger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells

(2009) Alvaro Valin et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Transgenic mice expressing small interfering RNA against Gata4 point to a crucial role of Gata4 in the heart and gonads

(2009) Boris Thurisch et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Novel pharmacotherapies to abrogate postinfarction ventricular remodeling

(2009) Gerald W. Dorn   Nature Reviews Cardiology

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Erythropoietin-Receptor Gene Regulation in Neuronal Cells

(2009) Iwona Wallach et al.   PEDIATRIC RESEARCH

Erythropoietin in cardioprotection: does it have a future or is it all in the past?

(2008) J. L. Mehta   CARDIOVASCULAR RESEARCH

The Wilms’ tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells

(2008) Karin M. Kirschner et al.   FASEB JOURNAL

Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury

(2008) Xiaohong Shan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart

(2008) Bin Zhou et al.   NATURE

Role of the Wilms’ tumour transcription factor, Wt1, in blood vessel formation

(2008) Holger Scholz et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Erythropoietin: ready for prime-time cardioprotection

(2008) Niels P. Riksen et al.   TRENDS IN PHARMACOLOGICAL SCIENCES